Angiotensin 2 type 1 receptor blockade different affects postishemic kidney injury in normotensive and hypertensive...

Area of Science:

• Nephrology
• Cardiovascular Research
• Pharmacology

Background:

• The role of the renin-angiotensin system in post-ischemic acute renal failure (ARF) is complex.
• Controversies exist regarding the net effect of angiotensin 2 type 1 receptor (AT1R) blockade on kidney structure and function after ischemia.

Purpose of the Study:

• To investigate the pathophysiological significance of the renin-angiotensin system in ARF development.
• To evaluate the effects of AT1R blockade in normotensive and hypertensive rat models of kidney ischemia.

Main Methods:

• Studies were conducted on normotensive Wistar rats and spontaneously hypertensive rats (SHR).
• Nitric oxide (NO) deficiency was induced using L-NAME at different doses.
• AT1R blockade was administered, and renal function, structure, and oxidative stress were assessed.

Main Results:

• In normotensive rats and those with mild NO deficiency, AT1R blockade offered minimal renal benefits, suggesting angiotensin 2 (Ang-2) is not dominant in these injury models.
• In rats with severe NO deficiency and ARF, AT1R blockade exacerbated tubular injury and impaired glomerular filtration.
• In contrast, AT1R antagonism in post-ischemic SHR improved glomerular filtration, reduced oxidative stress, and enhanced tubular structure, implicating Ang-2 in hypertensive kidney injury.

Conclusions:

• AT1R blockade has differential effects on kidney recovery depending on the underlying physiological state (normotensive vs. hypertensive) and NO availability.
• Caution is advised when using AT1R blockers in patients with ARF, especially those with compromised NO pathways.
• AT1R antagonism represents a promising therapeutic strategy for ARF in hypertensive individuals, potentially by mitigating Ang-2-mediated oxidative stress and improving tubular integrity.